Page last updated: 2024-10-22

antipyrine and Ventricular Fibrillation

antipyrine has been researched along with Ventricular Fibrillation in 1 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qin, T1
Lei, LY1
Li, N1
Shi, FR1
Chen, MH1
Xie, L1

Other Studies

1 other study available for antipyrine and Ventricular Fibrillation

ArticleYear
Edaravone improves survival and neurological outcomes after CPR in a ventricular fibrillation model of rats.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:10

    Topics: Animals; Antipyrine; Brain Injuries; Cardiopulmonary Resuscitation; Disease Models, Animal; Edaravon

2016